Showing results (1231-1240 of 1,246) with videos related to

Sort By:
Pageof 125
The Cochrane Database of Systematic Reviews|June 22, 2026
Audit and feedback: effects on professional practiceNoah Ivers, Sharlini Yogasingam, Meagan Lacroix, et al.
Nature Medicine|August 22, 2022
Neutralization titer biomarker for antibody-mediated prevention of HIV-1 acquisitionPeter B Gilbert, Yunda Huang, Allan C deCamp, et al.
Ebiomedicine|June 10, 2023
Pharmacokinetic serum concentrations of VRC01 correlate with prevention of HIV-1 acquisitionKelly E Seaton, Yunda Huang, Shelly Karuna, et al.
Solar Physics|June 16, 2023
Defining the Middle CoronaMatthew J West, Daniel B Seaton, David B Wexler, et al.
The Lancet. HIV|May 11, 2026
Safety, pharmacokinetics, and neutralisation activity of PGDM1400LS, VRC07-523LS, and PGT121.414.LS infused intravenously or subcutaneously (HVTN 140/HPTN 101 part B): a phase 1, randomised trialSharana Mahomed, Carmen A Paez, Yunda Huang, et al.
The Journal of Infectious Diseases|June 27, 2022
Analysis of the HIV Vaccine Trials Network 702 Phase 2b-3 HIV-1 Vaccine Trial in South Africa Assessing RV144 Antibody and T-Cell Correlates of HIV-1 Acquisition RiskZoe Moodie, One Dintwe, Sheetal Sawant, et al.
Science (New York, N.Y.)|August 1, 2015
HIV-1 VACCINES. Diversion of HIV-1 vaccine-induced immunity by gp41-microbiota cross-reactive antibodiesWilton B Williams, Hua-Xin Liao, M Anthony Moody, et al.
The Journal of Infectious Diseases|September 1, 2021
The Global Landscape of Pediatric Bacterial Meningitis Data Reported to the World Health Organization-Coordinated Invasive Bacterial Vaccine-Preventable Disease Surveillance Network, 2014-2019Tomoka Nakamura, Adam L Cohen, Stephanie Schwartz, et al.
Science Translational Medicine|July 30, 2025
Vaccination with mRNA-encoded membrane-anchored HIV envelope trimers elicited tier 2 neutralizing antibodies in a phase 1 clinical trialK Rachael Parks, Zoe Moodie, Mary A Allen, et al.
Ebiomedicine|September 5, 2024
Immune correlates analysis of the Imbokodo (HVTN 705/HPX2008) efficacy trial of a mosaic HIV-1 vaccine regimen evaluated in Southern African people assigned female sex at birth: a two-phase case-control studyAvi Kenny, Janine van Duijn, One Dintwe, et al.
Pageof 125